Why is cardiovascular risk stratification important in hypertensive patients?

Related Experiment Video

Updated: May 23, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Gabriel Coll-De-Tuero1, Marc Saez, Antonio Rodriguez-Poncelas

  • 1Primary Care, Health Care Institute, Parc Hospitalari Martí i Julià, Dr. Castany s/n, Salt, Girona, Spain. gabriel.coll@ias.scs.es

Blood Pressure
|April 11, 2012
PubMed

Insights

European Society of Hypertension guidelines effectively predict target organ damage progression in new hypertensive patients over one year. This risk stratification aids in managing cardiovascular health and preventing organ damage.

Area of Science:

  • Cardiology
  • Hypertension Management
  • Preventive Medicine

Background:

  • Cardiovascular risk stratification is crucial for managing newly diagnosed hypertensive patients.
  • The European Society of Hypertension (ESH) guidelines provide a framework for risk assessment.
  • Predicting the evolution of target organ damage (TOD) is essential for effective hypertension management.

Purpose of the Study:

  • To evaluate if ESH guideline-based cardiovascular (CV) risk stratification predicts TOD evolution in newly diagnosed hypertensive patients.
  • To assess the utility of routine clinical examinations in monitoring TOD over a 1-year period.
  • To determine the predictive value of initial CV risk assessment on long-term TOD progression.

Main Methods:

  • Prospective study of 479 newly diagnosed, untreated hypertensive patients.
  • Evaluated urinary albumin excretion rate (UAER), blood analysis, electrocardiogram, retinography, and blood pressure (BP) at baseline and 1 year.
  • Defined and assessed TOD evolution (favorable vs. unfavorable) based on ESH guidelines.

Main Results:

  • Patients with low/moderate CV risk showed significantly less unfavorable TOD evolution compared to high/very high-risk groups.
  • Specific findings include reduced rates of left ventricular hypertrophy (LVH), advanced fundus oculi (FO) damage, and high UAER in lower-risk patients.
  • Adjusted odds ratios indicated a substantially higher likelihood of favorable TOD evolution for low/moderate CV risk patients across all TOD markers.

Conclusions:

  • Routine clinical examinations are effective in detecting TOD variations in hypertensive patients within a 1-year follow-up.
  • ESH guideline-derived CV risk stratification accurately predicts the 1-year evolution of target organ damage.
  • This risk-based approach aids in proactive management and prevention of complications in hypertension.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...